SlideShare a Scribd company logo
1 of 1
Summary
My major contributions focus on the two major aspects in the drug discovery workflow:
Drug target discovery and mechanistic study:
1. Design and develop novel metabolic fluxomics platform for early drug target discovery,
pharmacological mechanism study, and unknown metabolite id. The readout analysis is for
understanding multiple pathway phenotypic responses to define fine tune condition for
pharmacological interventions.
2. Design and develop the LC-MS/MS based metabolomic and proteomic studies, using
chemical biology tools, for drug targets screening and validation.
Drug development: Compound screening, chemical series selection, lead development and
candidate selection
1. Develop in vitro enzyme assays for initial compound screening and mechanistic studies for
dissecting compound action – define chemical series/hits and chemical mechanism.
2. Design/develop cell based assay for compound screening – define chemical series/hits
(tool compound) for targets in the specific cell types.
3. Design and develop the LC-MS/MS based metabolomic and proteomic studies in animal
disease models to prove tool compound target engagements and pathway analysis.
Technical background:
- Spectroscopy/spectrometry (LC-MS/MS, intact protein MS, IR, UV/Vis, EPR etc) in small
molecule and protein biophysical characterization;
- Enzyme mechanistic study, enzyme kinetics, biochemical assay, protein-protein/ligand
interaction, oxygen-sensitive enzymes, stopped flow and fast mix coupled chemical/freeze
quench techniques;
- Protein expression, purification, engineering and modification;
- HPLC, FPLC (AKTA), LC-MS/UV-Vis (Waters), LC-MS/MS (AB Sciex QTRAP5500,
Thermo LCQ, LTQ, Orbitrap and QE plus, Waters LCT Premier), LC-chromatography in
glycolytic/TCA/pentose pathway/polyol pathway metabolites, lipids and proteomics (protein
modifications & quantitation), metabolomic tracer studies, metabolites cell/tissue extraction;
- Pharmaceutical industrial experience, diabetic/metabolic disease knowledge, method
development, good team player, mentoring experience, good communication, excellent trouble
shooting and problem solving skills;
- Proven record of creative work and critical contributions to move projects forward.
- Scientific publications in both industrial and academic settings.

More Related Content

Similar to Gang Xing - Summary

Lipidomics Bioinformatics Analysis
Lipidomics Bioinformatics AnalysisLipidomics Bioinformatics Analysis
Lipidomics Bioinformatics AnalysisCreative Proteomics
 
Applications of mass spectroscopy in pharmacy(including other sectors)
Applications of mass spectroscopy in pharmacy(including other sectors)Applications of mass spectroscopy in pharmacy(including other sectors)
Applications of mass spectroscopy in pharmacy(including other sectors)M R S
 
biologics and biosimilars.pptx
biologics and biosimilars.pptxbiologics and biosimilars.pptx
biologics and biosimilars.pptxARUNNT2
 
In vitro metabolite profiling
In vitro metabolite profilingIn vitro metabolite profiling
In vitro metabolite profilingTejaswini Jadhav
 
EricWaltersResume2016
EricWaltersResume2016EricWaltersResume2016
EricWaltersResume2016Eric Walters
 
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01lefein
 
Proteomics accelerates the drug discovery process
Proteomics accelerates the drug discovery processProteomics accelerates the drug discovery process
Proteomics accelerates the drug discovery processCreative Proteomics
 
Proteomics, A Major New Technology for Drug Discovery
Proteomics, A Major New Technology for Drug DiscoveryProteomics, A Major New Technology for Drug Discovery
Proteomics, A Major New Technology for Drug DiscoveryCreative Proteomics
 
Proteomics and pharmacoproteomics
Proteomics and pharmacoproteomicsProteomics and pharmacoproteomics
Proteomics and pharmacoproteomicsCreative Proteomics
 
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi
 
Significance of Bioanalysis in drug discovery and development
Significance of Bioanalysis in drug discovery and developmentSignificance of Bioanalysis in drug discovery and development
Significance of Bioanalysis in drug discovery and developmentDr. Manoj Kumbhare
 

Similar to Gang Xing - Summary (20)

Mpharm syallbas
Mpharm syallbasMpharm syallbas
Mpharm syallbas
 
Lipidomics Bioinformatics Analysis
Lipidomics Bioinformatics AnalysisLipidomics Bioinformatics Analysis
Lipidomics Bioinformatics Analysis
 
Kliachyna cv
Kliachyna cvKliachyna cv
Kliachyna cv
 
Proteomics
ProteomicsProteomics
Proteomics
 
Curriculum Vitae
Curriculum VitaeCurriculum Vitae
Curriculum Vitae
 
Applications of mass spectroscopy in pharmacy(including other sectors)
Applications of mass spectroscopy in pharmacy(including other sectors)Applications of mass spectroscopy in pharmacy(including other sectors)
Applications of mass spectroscopy in pharmacy(including other sectors)
 
biologics and biosimilars.pptx
biologics and biosimilars.pptxbiologics and biosimilars.pptx
biologics and biosimilars.pptx
 
20160223 Stennett L
20160223  Stennett L20160223  Stennett L
20160223 Stennett L
 
In vitro metabolite profiling
In vitro metabolite profilingIn vitro metabolite profiling
In vitro metabolite profiling
 
EricWaltersResume2016
EricWaltersResume2016EricWaltersResume2016
EricWaltersResume2016
 
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01
Biomarkersintoxicologyandclinicalresearch 120726101025-phpapp01
 
Proteomics accelerates the drug discovery process
Proteomics accelerates the drug discovery processProteomics accelerates the drug discovery process
Proteomics accelerates the drug discovery process
 
Proteomics, A Major New Technology for Drug Discovery
Proteomics, A Major New Technology for Drug DiscoveryProteomics, A Major New Technology for Drug Discovery
Proteomics, A Major New Technology for Drug Discovery
 
Proteomics and pharmacoproteomics
Proteomics and pharmacoproteomicsProteomics and pharmacoproteomics
Proteomics and pharmacoproteomics
 
Maha cv-linkedin-03 June,2015
Maha cv-linkedin-03 June,2015Maha cv-linkedin-03 June,2015
Maha cv-linkedin-03 June,2015
 
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
Srinivas Maddi CV _ Prinicipal scientist_ DMPK_ 2015
 
Maha cv-linkedin-06 june2015
Maha cv-linkedin-06 june2015Maha cv-linkedin-06 june2015
Maha cv-linkedin-06 june2015
 
Metabolomics
MetabolomicsMetabolomics
Metabolomics
 
Significance of Bioanalysis in drug discovery and development
Significance of Bioanalysis in drug discovery and developmentSignificance of Bioanalysis in drug discovery and development
Significance of Bioanalysis in drug discovery and development
 
QPS Biomarker Capabilities
QPS Biomarker CapabilitiesQPS Biomarker Capabilities
QPS Biomarker Capabilities
 

Gang Xing - Summary

  • 1. Summary My major contributions focus on the two major aspects in the drug discovery workflow: Drug target discovery and mechanistic study: 1. Design and develop novel metabolic fluxomics platform for early drug target discovery, pharmacological mechanism study, and unknown metabolite id. The readout analysis is for understanding multiple pathway phenotypic responses to define fine tune condition for pharmacological interventions. 2. Design and develop the LC-MS/MS based metabolomic and proteomic studies, using chemical biology tools, for drug targets screening and validation. Drug development: Compound screening, chemical series selection, lead development and candidate selection 1. Develop in vitro enzyme assays for initial compound screening and mechanistic studies for dissecting compound action – define chemical series/hits and chemical mechanism. 2. Design/develop cell based assay for compound screening – define chemical series/hits (tool compound) for targets in the specific cell types. 3. Design and develop the LC-MS/MS based metabolomic and proteomic studies in animal disease models to prove tool compound target engagements and pathway analysis. Technical background: - Spectroscopy/spectrometry (LC-MS/MS, intact protein MS, IR, UV/Vis, EPR etc) in small molecule and protein biophysical characterization; - Enzyme mechanistic study, enzyme kinetics, biochemical assay, protein-protein/ligand interaction, oxygen-sensitive enzymes, stopped flow and fast mix coupled chemical/freeze quench techniques; - Protein expression, purification, engineering and modification; - HPLC, FPLC (AKTA), LC-MS/UV-Vis (Waters), LC-MS/MS (AB Sciex QTRAP5500, Thermo LCQ, LTQ, Orbitrap and QE plus, Waters LCT Premier), LC-chromatography in glycolytic/TCA/pentose pathway/polyol pathway metabolites, lipids and proteomics (protein modifications & quantitation), metabolomic tracer studies, metabolites cell/tissue extraction; - Pharmaceutical industrial experience, diabetic/metabolic disease knowledge, method development, good team player, mentoring experience, good communication, excellent trouble shooting and problem solving skills; - Proven record of creative work and critical contributions to move projects forward. - Scientific publications in both industrial and academic settings.